Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women

Completed · Phase 2

Conditions studied: HIV Infections, Cachexia

In brief

OBJECTIVES: I. Determine whether physiologic testosterone replacement can increase fat-free mass, therefore contributing to weight maintenance, improved muscle function, and quality of life in HIV-infected women. II. Examine the mechanism of testosterone-induced increase in fat-free mass.

Key facts

Study ID

NCT00004400

Run by

Charles Drew University of Medicine and Science

People needed

56

Starts

1997-04-01

Expected to finish

2001-09-01

Last updated by the study team

2015-03-25

Who can join

Age: 18 and older, up to 50. Sex: female. Healthy volunteers: not accepted.

Where it is running

• Charles R. Drew University of Medicine and Science — Los Angeles, California, United States
• Los Angeles County Harbor-UCLA Medical Center — Torrance, California, United States
• Washington University School of Medicine — St Louis, Missouri, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.